Stay updated on Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.6.6) replacing the previous v3.6.5, indicating a new build of the site. This reflects a maintenance/version update rather than substantive changes to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-30T15:42:10.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, indicating an updated site deployment. The previous Revision: v3.6.4 label has been superseded.
    Difference
    0.1%
    Check dated 2026-08-09T00:34:52.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Removed the reference to the 2012 NEJM article Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. This background citation supported contextual information but is not part of the study's design, results, or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-01T22:55:40.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page shows a new revision tag v3.6.4 replacing the previous v3.6.3, indicating a minor patch or update to the page or system without visible content changes.
    Difference
    0.1%
    Check dated 2026-07-25T16:59:28.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page’s revision indicator was updated to v3.6.3, indicating a minor site update. This does not modify the study details or related data.
    Difference
    0.1%
    Check dated 2026-07-04T04:25:38.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    A classic NEJM trial reference on preoperative chemotherapy plus surgery for NSCLC was added, and the site revision tag was updated from v3.6.0 to v3.6.2.
    Difference
    0.1%
    Check dated 2026-06-27T03:05:41.000Z thumbnail image

Stay in the know with updates to Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in N2+ NSCLC Clinical Trial page.